Biogen wins another big Tecfidera patent case

For the second time in as many weeks, Biogen has prevailed in a high-stakes legal dispute over patents on its blockbuster multiple sclerosis treatment Tecfidera. The U.S. Patent Trial and Appeal Board on Friday rejected a bid by Danish biotech Forward Pharma (Nasdaq:...

Subscribe to get the latest news